Bravo Bruna Souza Felix, Carvalho Raquel de Melo
Clinica Bravo, Rio de Janeiro, Brazil.
J Cosmet Dermatol. 2021 May;20(5):1435-1438. doi: 10.1111/jocd.13597. Epub 2020 Aug 2.
Poly-L-lactic acid is presented as freeze-dried preparation of 150 mg per vial and, according to consensus, the recommendation on your preparation is hydrate in sterile water for injection (SWFI) or bacteriostatic water at room temperature for ≥24 hours. (J Drugs Dermatol; 2014;13:s44) However, in these long periods of hydration, it is time-consuming and costly for the physicians. To demonstrate the safeness of immediate reconstitution of facial biostimulation treatment with PLLA. A clinical prospective study with 26 Latin American female patients, aged between 27 and 80 years, complaining of facial laxity of treated with immediate PLLA reconstitution. One PLLA vial was injected per session in 12 mL total dilution. All patients had their pictures taken before and after the treatment in Photo Analysis Program Vectra 3D (Canfield ). A follow-up 90 days was performed. The total of 58 facial applications of PLLA was reported in female patients with a mean age 52.62 (±13.46) years. Pain was reported in 17 injections (29.31%) and ecchymosis in 6 (10.34%). Also, 2 patients (3.44%) developed a nodule. None of the patients presented significant bruising, edema, or papules formation. Despite the literature declare that a longer hydration times (up to 48 hours) have been shown to reduce the risk of nodule formation (Aesthet Surg J; 2011;31:95), our study demonstrated the safeness of injection with immediate reconstitution and a very low adverse events rate. Immediate PLLA reconstitution is a great asset for physicians, injections in account of being less laborious, less time-consuming, and reducing product loss for the injector.
聚左旋乳酸以每瓶150毫克的冻干制剂形式提供,根据共识,对于该制剂的建议是在室温下于注射用无菌水(SWFI)或抑菌水中水合≥24小时。(《药物皮肤病学杂志》;2014年;13:s44)然而,在这些长时间的水合过程中,对医生来说既耗时又费钱。为了证明聚左旋乳酸即刻复溶用于面部生物刺激治疗的安全性。对26名年龄在27至80岁之间、主诉面部松弛的拉丁美洲女性患者进行了一项临床前瞻性研究,采用聚左旋乳酸即刻复溶进行治疗。每次注射1瓶聚左旋乳酸,总稀释量为12毫升。所有患者在治疗前后均使用Vectra 3D照片分析程序(Canfield)拍照。进行了90天的随访。报告了58次聚左旋乳酸在女性患者面部的应用,平均年龄为52.62(±13.46)岁。17次注射(29.31%)报告有疼痛,6次(10.34%)有瘀斑。此外,2名患者(3.44%)出现了结节。没有患者出现明显的瘀伤、水肿或丘疹形成。尽管文献表明较长的水合时间(长达48小时)已被证明可降低结节形成的风险(《美容外科杂志》;2011年;31:95),但我们的研究证明了即刻复溶注射的安全性以及极低的不良事件发生率。聚左旋乳酸即刻复溶对医生来说是一项巨大的优势,因为注射操作更轻松、耗时更少,且减少了注射者的产品损耗。